Patients' willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations

Research in Social & Administrative Pharmacy : RSAP
Jamie C Barner, Andrea Branvold

Abstract

To determine what women would be willing to pay for pharmacist-provided menopause and hormone replacement therapy consultations and the relationship between willingness to pay (WTP) and patients' perceptions of importance of resolving menopausal symptoms, their satisfaction with physician services, their perceptions of pharmacists' abilities, and income. A convenience sample of 203 adult women using medications to treat menopause was recruited by their pharmacists. A self-administered survey was used to address the study objectives. The contingent valuation method was used to assess WTP in 4 scenarios (ie, 50% and 100% improvement in symptoms after a half-hour initial and a half-hour follow-up visit, respectively). Logistic regression analyses were used to assess the relationship between WTP and the independent variables. Two hundred and three surveys were returned resulting in a response rate of 41%. Across all 4 scenarios, at least 85% of women surveyed were willing to pay a minimum of 20 US dollars for pharmacist-provided menopause and hormone replacement therapy services. Respondents were willing to pay a median of 40 US dollars (for both 50% and 100% improvement) per half-hour for initial consultations, and 20 US dollars a...Continue Reading

References

Dec 15, 1992·Annals of Internal Medicine·D GradyS R Cummings
Apr 1, 1992·British Journal of Obstetrics and Gynaecology·P J RyanI Fogelman
Apr 1, 1990·Obstetrics and Gynecology·L E Nachtigall
Jan 1, 1989·Archives of Internal Medicine·K J FergusonS Johnson
May 1, 1987·American Journal of Obstetrics and Gynecology·V A Ravnikar
Mar 1, 1995·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D J TorgersonD M Reid
Feb 1, 1994·Journal of Clinical Pharmacy and Therapeutics·P R Gore, S Madhavan
Feb 1, 1997·Social Science & Medicine·M RyanJ Tucker
Jun 1, 1997·Social Science & Medicine·S D RamseyD L Patrick
Dec 10, 1990·Journal of Health Economics·M JohannessonL Borgquist
Mar 9, 1993·Journal of Health Economics·M JohannessonU G Gerdtham
Aug 24, 1999·Annals of Internal Medicine·M T ConnellyT S Inui
Jan 26, 2000·Menopause : the Journal of the North American Menopause Society
Apr 3, 2002·Journal of the American Pharmaceutical Association : APhA·Jennifer Cerulli
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators

❮ Previous
Next ❯

Citations

Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Shane P Desselle
Jul 4, 2013·Research in Social & Administrative Pharmacy : RSAP·Judith A Singleton, Lisa M Nissen
Feb 15, 2018·International Journal of Clinical Pharmacy·Pankti A GheewalaRonald L Castelino
Aug 29, 2009·PharmacoEconomics·Andrej RaschWolfgang Greiner
Mar 1, 2013·Therapeutic Innovation & Regulatory Science·Sally A HustonSujit S Sansgiry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved